Lupin Receives U.S. FDA Tentative Approval for Enzalutamide Tablets
MUMBAI, India & NAPLES, Fla., June 26, 2026 Lupin Limited announced that it has received tentative approval from the...
Bioequivalence
Advertisement
Lupin Launches Dapagliflozin Tablets in U.S. Market
Mumbai, India & Naples, Florida | April 10, 2026 Lupin Limited has announced the U.S. launch of Dapagliflozin Tablets...
DifGen, Apotex Win FDA Approval for Nintedanib Capsules
MIRAMAR, Fla., April 9, 2026 DifGen Pharmaceuticals LLC, in collaboration with Apotex Inc., has announced that the U.S. Food...
Glenmark Pharmaceuticals Gains FDA Nod for Progesterone
ELMWOOD PARK, New Jersey, April 9, 2026 Glenmark Pharmaceuticals Limited has received final approval from the U.S. Food and...
Lupin Launches Topiramate ER Capsules in United States
MUMBAI, India & NAPLES, Fla., Feb. 4, 2026 — Global pharmaceutical company Lupin Limited announced the U.S. launch of...
Advertisement
